Apply for funding to design novel interventions, Technology Readiness Level (TRL) two to four, for non-compressible haemorrhage (NCH) for use prehospital in both combat and civilian settings.
This Defence and Security Accelerator (DASA) competition is run on behalf of DMS and UK Research and Innovation (UKRI).
Projects will last up to three years, with an expected start date of April 2026.
DASA welcomes submissions from academia, public sector research establishments and the private sector. DASA will examine the legal status of organisations prior to placement of any contract or agreement. You can find more information in the DASA standard terms and conditions.
We are looking to fund applications to develop novel innovations that intervene to stop non-compressible bleeding. In this case ‘novel’ refers to products currently between TRL two to four, ideally at TRL two or three. We are not seeking to support innovations that have already progressed beyond TRL four. We expect funded products to progress by one or more TRLs by the end of the project.
NCH refers to significant bleeding that cannot be immediately stopped or sustainably controlled from application of external pressure. NCH may arise from injury to blood vessels and organs in the body where such external pressure cannot be applied or where application is challenging.
Your application should involve novel engineering technology-driven, design-led solutions aimed at device-enabled control of haemorrhage. We encourage solutions that exploit and integrate existing technologies or approaches used or developed in non-healthcare sectors that could be re-oriented at the NCH challenge. We welcome novel applications that can readily translate in-hospital solutions for use in the unique operating environment of the pre-hospital, pre-physician domain, close to point of injury.
We particularly welcome applications which will bring together applicants from disparate disciplines and sectors to develop novel devices.
It is envisaged that successful projects will secure further funding from other sources to progress through TRLs. These sources might include research councils under UKRI, the National Institute for Health and Care Research, future DASA open funding opportunities, or venture capital funding.
We want novel ideas to benefit end-users working in UK defence and security and in civilian settings. Your application should include evidence of:
Applications focused on the following are out of scope.
Products that:
We are not looking for applications that offer:
The duration of this award is a minimum of three years.
We expect projects to start in April 2026.
You must complete an application through the Ministry of Defence’s DASA.
For more guidance on how to apply, refer to the novel technology for intervening in NCH external funding opportunity on GOV.UK
You must submit your application by 4 November 2025 at 12:00pm UK time.
You will not be able to apply after this time.
Make sure you are aware of and follow any internal institutional deadlines.
For further information, see the competition document: novel technology for intervening in NCH on GOV.UK.
Explore the DASA assessment process (GOV.UK).
For additional information on specific assessment criteria for this opportunity see the DASA novel technology for intervening in NCH funding opportunity (GOV.UK).
Find more detailed guidance and points of contact on the funding opportunity, novel technology for intervening in NCH (GOV.UK).
